Edwards Lifesciences Corp Financing Cash Flow 2008-2026 | EW
Beta
What is financing cash flow?
Financing cash flow represents cash from or used in financing activities, including borrowing, repaying debt, issuing or repurchasing stock, and paying dividends.
What is Edwards Lifesciences Corp's current financing cash flow?
Edwards Lifesciences Corp (EW) annual financing cash flow for 2025 was $-956.8M, a 2.67% increase from 2024. Edwards Lifesciences Corp financing cash flow for the quarter ending March 31, 2026 was $-451.2M.
What was Edwards Lifesciences Corp's financing cash flow in 2024?
Edwards Lifesciences Corp annual financing cash flow for 2024 was $-983.0M, a 38.26% decline from 2023.
What was Edwards Lifesciences Corp's financing cash flow in 2023?
Edwards Lifesciences Corp annual financing cash flow for 2023 was $-711.0M, a 55.13% increase from 2022.
Financing Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$-486.9M
→
FY2025
$-956.8M
080910111213141516171819202122232425
5 years selected
Financing Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-956.8M | +2.7% | 10-K |
| FY2024 | $-983.0M | -38.3% | 10-K |
| FY2023 | $-711.0M | +55.1% | 10-K |
| FY2022 | $-1.58B | -344.7% | 10-K |
| FY2021 | $-356.3M | +26.8% | 10-K |
| FY2020 | $-486.9M | -321.2% | 10-K |
| FY2019 | $-115.6M | +89.5% | 10-K |
| FY2018 | $-1.10B | -132.7% | 10-K |
| FY2017 | $-473.2M | -76.2% | 10-K |
| FY2016 | $-268.5M | -69.3% | 10-K |
| FY2015 | $-158.6M | -3.7% | 10-K |
| FY2014 | $-153.0M | -538.4% | 10-K |
| FY2013 | $34.9M | +122.4% | 10-K |
| FY2012 | $-155.6M | -15.1% | 10-K |
| FY2011 | $-135.2M | -30.1% | 10-K |
| FY2010 | $-103.9M | -13.2% | 10-K |
| FY2009 | $-91.8M | +31.5% | 10-K |
| FY2008 | $-134.1M | - | 10-K |
Company: Edwards Lifesciences CorpTicker: EWSector: OtherIndustry: Orthopedic, Prosthetic & Surgical Appliances & SuppliesView company profile →